Novartis Announces EU approval for Farydak By: Benzinga via Benzinga September 04, 2015 at 04:45 AM EDT Novartis (NYSE: NVS) announced today that the European Commission has approved Farydak(R) (panobinostat, previously known as LBH589) ... Read More >> Related Stocks: Novartis Ag ADR